Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 8:15:1338544.
doi: 10.3389/fphys.2024.1338544. eCollection 2024.

Integrating mitoepigenetics into research in mood disorders: a state-of-the-art review

Affiliations
Review

Integrating mitoepigenetics into research in mood disorders: a state-of-the-art review

Deniz Ceylan et al. Front Physiol. .

Abstract

Mood disorders, including major depressive disorder and bipolar disorder, are highly prevalent and stand among the leading causes of disability. Despite the largely elusive nature of the molecular mechanisms underpinning these disorders, two pivotal contributors-mitochondrial dysfunctions and epigenetic alterations-have emerged as significant players in their pathogenesis. This state-of-the-art review aims to present existing data on epigenetic alterations in the mitochondrial genome in mood disorders, laying the groundwork for future research into their pathogenesis. Associations between abnormalities in mitochondrial function and mood disorders have been observed, with evidence pointing to notable changes in mitochondrial DNA (mtDNA). These changes encompass variations in copy number and oxidative damage. However, information on additional epigenetic alterations in the mitochondrial genome remains limited. Recent studies have delved into alterations in mtDNA and regulations in the mitochondrial genome, giving rise to the burgeoning field of mitochondrial epigenetics. Mitochondrial epigenetics encompasses three main categories of modifications: mtDNA methylation/hydroxymethylation, modifications of mitochondrial nucleoids, and mitochondrial RNA alterations. The epigenetic modulation of mitochondrial nucleoids, lacking histones, may impact mtDNA function. Additionally, mitochondrial RNAs, including non-coding RNAs, present a complex landscape influencing interactions between the mitochondria and the nucleus. The exploration of mitochondrial epigenetics offers valuable perspectives on how these alterations impact neurodegenerative diseases, presenting an intriguing avenue for research on mood disorders. Investigations into post-translational modifications and the role of mitochondrial non-coding RNAs hold promise to unravel the dynamics of mitoepigenetics in mood disorders, providing crucial insights for future therapeutic interventions.

Keywords: bipolar disorder; epigenetics; major depression; mitochondrial dysfunction; mitoepigenetics; mood disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The research about mtDNA modifications focuses on changes in mtDNA copy numbers and oxidation levels, in addition to mitoepigenetic changes in mood disorders. Different types of modifications have been identified for mitoepigenetics. (1) mtDNA methylation/hydroxymethylation; (2) modifications of mitochondrial nucleoids; (3) mitochondrial RNA modifications and modulation of non-coding RNAs (ncRNA) originating from nuclear DNA or mtDNA. (Created with BioRender.com).

References

    1. Ahmadimanesh M., Abbaszadegan M. R., Morshedi Rad D., Moallem S. A., Mohammadpour A. H., Ghahremani M. H., et al. (2019). Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression. J. Psychopharmacol. 33, 1364–1376. 10.1177/0269881119874461 - DOI - PubMed
    1. Akula N., Barb J., Jiang X., Wendland J. R., Choi K. H., Sen S. K., et al. (2014). RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol. Psychiatry 19, 1179–1185. 10.1038/mp.2013.170 - DOI - PMC - PubMed
    1. Allen J., Romay-Tallon R., Brymer K. J., Caruncho H. J., Kalynchuk L. E. (2018). Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front. Neurosci. 12, 386. 10.3389/fnins.2018.00386 - DOI - PMC - PubMed
    1. Araujo L. F., Siena A. D. D., Plaça J. R., Brotto D. B., Barros, Muys B. R., et al. (2018). Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma. Sci. Rep. 8, 14190. 10.1038/s41598-018-31170-6 - DOI - PMC - PubMed
    1. Bansal Y., Kuhad A. (2016). Mitochondrial dysfunction in depression. Curr. Neuropharmacol. 14, 610–618. 10.2174/1570159x14666160229114755 - DOI - PMC - PubMed

LinkOut - more resources